COO, CFO and Secretary
Wed, Feb 15, 2023
Feb 15
2,250 shares @ $0.00
Increased holdings by +0.80%
130th largest trade (out of 143)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
67% win rate · +2.3% median edge vs SPY (12 trades, 90-day · small sample)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology